Ionis Pharmaceuticals (IONS) PT Raised to $67 at BMO Capital; Buy on Weakness

July 25, 2017 1:51 PM

BMO Capital raised its price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $67.00 (from $62.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found